A Randomized Trial of Anticoagulation Strategies in COVID-19:PROTECT-COVID 19
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Covid-19
-
Age: Between 18 years - 120 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Subjects who are hospitalized with diagnosis of COVID-19
- Subjects with D-dimer > 500ng/ml (hypercoagulability)
You may not be eligible for this study if the following are true:
-
- Subjects with indication for therapeutic anticoagulation
- Subjects with COVID related “high-risk” indication for therapeutic anticoagulation
- Renal failure
- D-dimer >10,000 ng/ml, markedly increasing D-dimer
- Had prior Heparin induced thrombocytopenia within 100 days
- Had a stroke within 30 days
- Had prior hemorrhagic stroke (ever)
- Had Gastrointestinal bleeding within the past 6 months.
- Subjects with platelet count <100,000
- Has anemia with a hemoglobin <9mg/dl
- Subjects with signs of active bleeding or other bleeding risks
- Subjects who are pregnant
- Subjects who have no capacity to consent themselves
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.